Identity on this record
Chemical name: CJC-1295 (GRF(1-29) analogue).
Common synonyms: Modified GRF 1-29 (no-DAC form), CJC-1295 DAC.
Parent sequence: Growth hormone-releasing hormone fragment 1-29.
Receptor target: GHRH receptor.
Appearance: White lyophilised powder.
Catalog availability: Supplied as part of the CJC-1295 / Ipamorelin dual kit.
Those identifiers describe CJC-1295 as a substance. They do not describe a particular vial. The vial is identified by the name, the nominal fill, and the lot number on its label, checked against the published certificate.
What the catalogue actually sells
CJC-1295 (no DAC) 5mg + Ipamorelin 5mg is the 5 mg + 5 mg lyophilized unit, listed at AED 399 before VAT. The product record stores that sealed unit at 2–8 °C.
Prices are merchandise prices in AED, exclusive of VAT. VAT is added at checkout. A price on this summary is the figure on the product record for CJC-1295, not a delivered-cost quote.
Lots and certificates
Lot 238930 for CJC-1295 (no DAC) 5mg + Ipamorelin 5mg is a Janoshik Analytical report. The published record states Content reported. Figures printed on the report: Ipamorelin 4.83 mg; CJC-1295 (mod GRF 1-29) 4.68 mg. Method line on that report: CJC No DAC - MOD GRF (1-29)/Ipamorelin blend analysis. The laboratory file is linked from the certificate page. Open CJC-1295 (no DAC) 5mg + Ipamorelin 5mg certificate or match lot 238930 in batch verification. That report qualifies this lot only.
Lot VL-CJCIPA-20260321 is the catalogue certificate for CJC-1295 (no DAC) 5mg + Ipamorelin 5mg. Read it on CJC-1295 (no DAC) 5mg + Ipamorelin 5mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.
CJC-1295 has both a laboratory report and catalogue certificates. Janoshik Analytical lot 238930 is the third-party file. The other lot numbers are catalogue certificates for their own fills. Match the printed lot. Do not treat one purity line as the result for every vial.
How the compound record describes the literature
Modified GRF (1-29) analogs were developed to extend half-life in research models. CJC-1295 nomenclature appears widely in peptide research supply and preclinical literature.
Topics named on the CJC-1295 record, as literature context rather than as outcomes VaultLabs claims: Pituitary cell culture models; GH release assay systems; GHRH receptor binding studies; Combination protocol literature (with GHRP peptides).
That is context for identifying CJC-1295. It is not a claim that a vial produces a result in a person, an animal, or a study VaultLabs has not published. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
Points the monograph already states
Points already written on the CJC-1295 monograph, so a reader can check them against that page:
Based on GRF(1-29), the shortest fragment of growth hormone-releasing hormone that retains activity in the literature.
Two versions share the name: CJC-1295 with DAC, which carries a linker allowing albumin binding, and CJC-1295 without DAC, essentially modified GRF(1-29). Confirm which one a certificate describes.
Acts on the GHRH receptor, a different target from ghrelin-receptor secretagogues such as ipamorelin — which is why the two are studied together.
Growth hormone-releasing factors and their analogues are prohibited in sport under the World Anti-Doping Agency list.
Not an approved medicine in any jurisdiction; supplied strictly for in vitro research.
Dispatch and the research-use boundary
VaultLabs dispatches CJC-1295 from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
The full narrative record is the CJC-1295 compound monograph. Handling of the sealed unit is the CJC-1295 storage guide. Questions are collected on the CJC-1295 FAQ. How it differs from neighbouring records is the CJC-1295 comparison.